GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hubei Hongyuan Pharmaceutical Technology Co Ltd (SZSE:301246) » Definitions » Scaled Net Operating Assets

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Scaled Net Operating Assets : 0.48 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hubei Hongyuan Pharmaceutical Technology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hubei Hongyuan Pharmaceutical Technology Co's operating assets for the quarter that ended in Mar. 2024 was ¥3,618 Mil. Hubei Hongyuan Pharmaceutical Technology Co's operating liabilities for the quarter that ended in Mar. 2024 was ¥901 Mil. Hubei Hongyuan Pharmaceutical Technology Co's Total Assets for the quarter that ended in Dec. 2023 was ¥5,651 Mil. Therefore, Hubei Hongyuan Pharmaceutical Technology Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2024 was 0.48.


Hubei Hongyuan Pharmaceutical Technology Co Scaled Net Operating Assets Historical Data

The historical data trend for Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Hongyuan Pharmaceutical Technology Co Scaled Net Operating Assets Chart

Hubei Hongyuan Pharmaceutical Technology Co Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.60 0.93 0.89 0.73

Hubei Hongyuan Pharmaceutical Technology Co Quarterly Data
Jun15 Dec15 Jun16 Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.40 0.48 0.51 0.48

Competitive Comparison of Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets falls into.



Hubei Hongyuan Pharmaceutical Technology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(3763.048-941.419)/3875.465
=0.73

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5650.771 - 1887.723
=3763.048

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1290.933 - 283.015 - 66.499
=941.419

Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2024 )
=(Operating Assets (Q: Mar. 2024 )-Operating Liabilities (Q: Mar. 2024 ))/Total Assets (Q: Dec. 2023 )
=(3618.224-901.272)/5650.771
=0.48

where

Operating Assets(Q: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=5640.263 - 2022.039
=3618.224

Operating Liabilities(Q: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1247.753 - 280.927 - 65.554
=901.272

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hubei Hongyuan Pharmaceutical Technology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Hubei Hongyuan Pharmaceutical Technology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Hongyuan Road, Economic Development Zone, Luotian County, Hubei Province, Fengshan Town, CHN, 438600
Hubei Hongyuan Pharmaceutical Technology Co Ltd is engaged in the research and development, production and sales of organic chemical raw materials, pharmaceutical intermediates, raw materials and pharmaceutical preparations.

Hubei Hongyuan Pharmaceutical Technology Co (SZSE:301246) Headlines

No Headlines